Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology

Guan-Hua Su(Fudan University Shanghai Cancer Center), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University), Yi Xiao(Fudan University Shanghai Cancer Center)
Cell Reports Medicine
December 1, 2022
10.1016/j.xcrm.2022.100808
Cited by 4

Related Papers

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
|Cell Research|2022|315
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171
Radiomics in breast cancer: Current advances and future directions
|Cell Reports Medicine|2024|143
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
|Science Advances|2023|114
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer
|Molecular Cancer|2020|92